AIOME is the Chelonia project fully committed to an higher precision medicine approach of health care. AIOME aims to become the artificial intelligence-powered biotech leveraging its proprietary platform to map disease and revolutionize treatments across different conditions and diseases.

By harnessing the power of Artificial Intelligence coupled with multi -omics approach and microbiota fingerprint of patients, the project aims to accelerate clinical identification and pursuit of promising therapeutic targets to treat disease. This means more effective precision treatments for individuals as well as a reduction in costs to the healthcare systems.

©2020 by CHELONIA SA (AG)